QuidelOrtho Corporation (QDEL) Financial Ratios
31 years of historical data (1995–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↑
N/A
—
5yr avg: 8.14
30Y Low5.3·High87.3
P/FCF
↑
N/A
—
5yr avg: 29.11
30Y Low6.4·High143.4
P/B Ratio
↓
0.39
↓-72% vs avg
5yr avg: 1.40
30Y Low1.0·High6.4
ROE
↓
-46.1%
↑-499% vs avg
5yr avg: -7.7%
30Y Low-51%·High86%
Debt/EBITDA
↑
N/A
—
5yr avg: 2.35
30Y Low0.1·High13.7
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
QDEL Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
QuidelOrtho Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $746M | $2.0B | $3.0B | $4.9B | $4.9B | $5.8B | $7.8B | $3.2B | $2.1B | $1.5B | $701M |
| Enterprise Value | $3.4B | $4.6B | $5.6B | $7.4B | $7.5B | $5.1B | $7.4B | $3.3B | $2.1B | $1.8B | $680M |
| P/E Ratio → | -0.66 | — | — | — | 8.96 | 8.22 | 9.66 | 43.37 | 28.06 | — | — |
| P/S Ratio | 0.27 | 0.73 | 1.07 | 1.64 | 1.51 | 3.41 | 4.71 | 6.05 | 3.98 | 5.27 | 3.66 |
| P/B Ratio | 0.39 | 1.03 | 1.00 | 0.98 | 1.00 | 3.00 | 5.88 | 5.78 | 4.88 | 6.44 | 3.49 |
| P/FCF | — | — | — | 69.44 | 6.61 | 11.28 | 13.86 | 30.16 | 19.85 | 143.38 | — |
| P/OCF | 7.09 | 18.88 | 35.83 | 17.57 | 5.55 | 7.18 | 12.44 | 24.05 | 15.24 | 52.78 | 59.30 |
P/E links to full P/E history page with 30-year chart
QDEL EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.69 | 2.00 | 2.47 | 2.29 | 3.02 | 4.48 | 6.16 | 4.10 | 6.57 | 3.55 |
| EV / EBITDA | — | — | — | 12.44 | 6.63 | 5.34 | 6.71 | 23.44 | 15.06 | 45.24 | 24.77 |
| EV / EBIT | — | — | — | 49.52 | 9.22 | 5.69 | 7.10 | 35.82 | 24.43 | 190.93 | — |
| EV / FCF | — | — | — | 104.63 | 10.04 | 9.99 | 13.19 | 30.71 | 20.46 | 178.81 | — |
QDEL Profitability
Margins and return-on-capital ratios measuring operating efficiency
QuidelOrtho Corporation earns an operating margin of -33.7%. Operating margins have compressed from 4.6% to -33.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -46.1% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.7% | 46.7% | 46.2% | 49.9% | 59.3% | 75.3% | 81.2% | 60.0% | 60.4% | 56.2% | 61.7% |
| Operating Margin | -33.7% | -33.7% | -70.5% | 4.6% | 25.8% | 53.3% | 63.8% | 17.3% | 18.4% | 3.4% | -2.3% |
| Net Profit Margin | -41.5% | -41.5% | -73.7% | -0.3% | 16.8% | 41.5% | 48.8% | 13.6% | 14.2% | -2.9% | -7.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -46.1% | -46.1% | -51.4% | -0.2% | 16.0% | 43.2% | 85.6% | 14.8% | 22.7% | -3.8% | -6.6% |
| ROA | -18.6% | -18.6% | -27.4% | -0.1% | 9.7% | 32.7% | 58.3% | 8.5% | 8.5% | -1.2% | -3.5% |
| ROIC | -13.6% | -13.6% | -22.5% | 1.4% | 14.5% | 61.3% | 101.3% | 12.5% | 13.3% | 1.9% | -1.9% |
| ROCE | -18.0% | -18.0% | -29.8% | 1.8% | 16.9% | 49.8% | 91.4% | 13.0% | 13.2% | 1.6% | -1.2% |
QDEL Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $2.6B ($2.8B total debt minus $170M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.46 | 1.46 | 0.90 | 0.52 | 0.58 | 0.07 | 0.08 | 0.20 | 0.25 | 1.75 | 0.74 |
| Debt / EBITDA | — | — | — | 4.38 | 2.53 | 0.15 | 0.10 | 0.80 | 0.76 | 9.86 | 5.41 |
| Net Debt / Equity | — | 1.37 | 0.87 | 0.50 | 0.52 | -0.34 | -0.29 | 0.11 | 0.15 | 1.59 | -0.11 |
| Net Debt / EBITDA | — | — | — | 4.18 | 2.27 | -0.69 | -0.34 | 0.42 | 0.45 | 8.96 | -0.77 |
| Debt / FCF | — | — | — | 35.19 | 3.43 | -1.29 | -0.68 | 0.55 | 0.61 | 35.43 | — |
| Interest Coverage | -5.24 | -5.24 | -10.32 | 0.84 | 10.88 | 1286.57 | 831.31 | 6.22 | 3.61 | 0.54 | -0.33 |
QDEL Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.50x means QuidelOrtho Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.90x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.57x to 1.50x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.50 | 1.50 | 1.22 | 1.57 | 1.56 | 4.45 | 3.39 | 1.77 | 1.21 | 2.58 | 6.71 |
| Quick Ratio | 0.90 | 0.90 | 0.69 | 0.88 | 1.04 | 3.84 | 3.05 | 1.30 | 0.79 | 2.06 | 5.93 |
| Cash Ratio | 0.21 | 0.21 | 0.10 | 0.20 | 0.34 | 2.56 | 1.45 | 0.42 | 0.27 | 0.28 | 5.04 |
| Asset Turnover | — | 0.47 | 0.43 | 0.35 | 0.37 | 0.70 | 0.89 | 0.59 | 0.65 | 0.30 | 0.49 |
| Inventory Turnover | 2.52 | 2.52 | 2.80 | 2.60 | 2.54 | 2.11 | 2.75 | 3.69 | 3.07 | 1.81 | 2.82 |
| Days Sales Outstanding | — | 55.75 | 59.19 | 59.47 | 65.53 | 84.62 | 116.24 | 69.84 | 53.73 | 102.98 | 47.61 |
QDEL Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
QuidelOrtho Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 11.2% | 12.2% | 10.4% | 2.3% | 3.6% | — | — |
| FCF Yield | — | — | — | 1.4% | 15.1% | 8.9% | 7.2% | 3.3% | 5.0% | 0.7% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.1% | 1.5% | 1.8% | 0.6% | 0.0% | 0.2% | 0.0% | 2.9% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.1% | 1.5% | 1.8% | 0.6% | 0.0% | 0.2% | 0.0% | 2.9% |
| Shares Outstanding | — | $68M | $67M | $67M | $57M | $43M | $44M | $43M | $43M | $34M | $33M |
Peer Comparison
Compare QDEL with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 QDELYou | $746M | -0.7 | — | — | 46.7% | -33.7% | -46.1% | -13.6% | — |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 BIO | $7B | 9.3 | 16.8 | 18.7 | 52.0% | 10.5% | 10.8% | 2.6% | 3.2 |
 NEOG | $2B | -1.8 | 20.6 | — | 47.1% | 1.1% | -41.9% | 0.2% | 6.8 |
 IDXX | $46B | 44.3 | 32.1 | 43.8 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 |
 ALGN | $12B | 30.8 | 14.4 | 25.4 | 68.3% | 15.3% | 10.4% | 15.4% | 0.1 |
 OSUR | $216M | -3.2 | — | — | 41.9% | -59.2% | -18.3% | -20.0% | — |
 ABT | $150B | 11.3 | 15.7 | 23.6 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 DHR | $124B | 34.7 | 18.1 | 23.5 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 |
 BDX | $52B | 24.8 | 14.0 | 19.6 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 LH | $21B | 24.6 | 12.7 | 17.5 | 26.8% | 10.9% | 10.5% | 7.8% | 3.3 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
See QDEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs QDEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare QDEL vs HOLX
Side-by-side business, growth, and profitability comparison vs Hologic, Inc..
Start ComparisonQDEL — Frequently Asked Questions
Quick answers to the most common questions about buying QDEL stock.
What is QuidelOrtho Corporation's P/E ratio?
QuidelOrtho Corporation's current P/E ratio is -0.7x. The historical average is 51.2x.
What is QuidelOrtho Corporation's ROE?
QuidelOrtho Corporation's return on equity (ROE) is -46.1%. The historical average is 6.2%.
Is QDEL stock overvalued?
Based on historical data, QuidelOrtho Corporation is trading at a P/E of -0.7x. Compare with industry peers and growth rates for a complete picture.
What are QuidelOrtho Corporation's profit margins?
QuidelOrtho Corporation has 46.7% gross margin and -33.7% operating margin.